Finance

Lists
IONS:BMV
Ionis Pharmaceuticals Inc
MX$960.00
-4.95%
(-50.00) 1D
Sep 4, 2:00:00 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for IONS...
Open
MX$960.00
High
MX$960.00
Low
MX$960.00
Mkt. cap
9.65B
Avg. vol.
2.00
Volume
50.00
52-wk high
MX$1,180.00
52-wk low
MX$647.00
No. of employees
1K
Open
MX$960.00
High
MX$960.00
Low
MX$960.00
Mkt. cap
9.65B
Avg. vol.
2.00
Volume
50.00
52-wk high
MX$1,180.00
52-wk low
MX$647.00
No. of employees
1K
News stories
From web sources and news partners
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1.48K
Founded1989
HeadquartersCarlsbad, California, United States
SectorBiotechnology
Websiteionis.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
156.72M
203.33M
246.09M
267.95M
Cost of goods sold
220.09M
287.60M
213.16M
208.75M
Cost of revenue
220.09M
287.60M
213.16M
208.75M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
96.81M
130.19M
150.36M
160.60M
Operating expense
96.81M
130.19M
150.36M
161.50M
Total operating expenses
316.90M
417.79M
363.52M
370.24M
Operating income
-160.18M
-214.46M
-117.42M
-102.29M
Other non operating income
363.00K
57.00K
-456.00K
987.00K
EBT including unusual items
-128.39M
-227.92M
-92.31M
-113.38M
EBT excluding unusual items
-158.30M
-212.36M
-114.89M
-103.20M
Income tax expense
213.00K
1.48M
218.00K
1.26M
Effective tax rate
-0.17%
-0.65%
-0.24%
-1.11%
Other operating expenses
-
-
-
900.00K
Net income
-128.61M
-229.39M
-92.53M
-114.65M
Net profit margin
-82.06%
-112.82%
-37.60%
-42.79%
Earnings per share
-0.61
-1.15
-0.30
-0.42
Interest and investment income
23.68M
24.73M
25.48M
20.23M
Interest expense
-22.16M
-22.69M
-22.50M
-22.12M
Net interest expenses
1.52M
2.04M
2.99M
-1.89M
Depreciation and amortization charges
-
-
-
-
EBITDA
-157.31M
-210.56M
-113.46M
-98.16M
Gain or loss from assets sale
-3.94M
638.00K
40.00K
441.00K
AI content may include mistakes. Learn more
Google apps